Researchers from the Department of Neurobiology, Care Sciences and Society (Eriksdotter group) in collaboration with the Departments of MEB (Carrero group) and Clintec (Bruchfeld group)…
A recent study led by Dr. Louise Mewton at UNSW’s Centre for Healthy Brain Aging (CHeBA) has reignited the debate about whether low levels of…
When Emily Largent worked as an ICU nurse at UCLA, she didn’t shy away from the difficult cases. It wasn’t necessarily the medical procedures themselves…
The first drug that can slow the rate of decline in Alzheimer’s patients has been found. The experimental drug, called lecanemab, is an antibody that…
Dementia patients who suffer from seizures tend to decline faster and die younger, according to a new study that urges caregivers to watch for these…
Two early stage clinical studies testing the safety and efficacy of 40Hz sensory stimulation to treat Alzheimer’s disease have found that the potential therapy was…
The formation of amyloid plaques in the brain is a hallmark of Alzheimer’s disease. But drugs designed to reduce accumulations of these plaques have so…
Despite decades of research, Alzheimer’s disease remains a debilitating and eventually fatal dementia with no effective treatment options. More than 95 percent of Alzheimer’s disease…
A new study has identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and another blood test that is optimal…
In a new study published in Translational Psychiatry, researchers at the Global Brain Health Institute (GBHI) and the School of Psychology at Trinity College describe…